- パブリケーション
更新日：2026.10.22
Yuichi Hori et al.
Long-Term Safety and Clinical Outcomes of Motugivatrep (SJP-0132) 0.3% Ophthalmic Suspension in Patients with Dry Eye Disease: An Open-Label, Phase 3 Study
2026 Sep 26:20:615529.
doi: 10.2147/OPTH.S615529.